Hyku Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Hyku Biosciences's estimated annual revenue is currently $4.2M per year.
- Hyku Biosciences's estimated revenue per employee is $155,000
- Hyku Biosciences's total funding is $64M.
Employee Data
- Hyku Biosciences has 27 Employees.
- Hyku Biosciences grew their employee count by 0% last year.
Hyku Biosciences's People
| Name | Title | Email/Phone | 
|---|---|---|
| 1 | President and CEO | Reveal Email/Phone | 
| 2 | Chief Scientific Officer | Reveal Email/Phone | 
| 3 | VP | Reveal Email/Phone | 
| 4 | VP Biology | Reveal Email/Phone | 
| 5 | VP Medicinal Chemistry | Reveal Email/Phone | 
| 6 | VP, Biology | Reveal Email/Phone | 
| 7 | VP, Corporate Development | Reveal Email/Phone | 
| 8 | Director, Cancer Biology | Reveal Email/Phone | 
| 9 | Director, Biomolecular Sciences | Reveal Email/Phone | 
| 10 | Director, Medicinal Chemistry | Reveal Email/Phone | 
Hyku Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation | 
|---|---|---|---|---|---|
| #1 | $12.7M | 82 | -45% | $107.3M | N/A | 
| #2 | $0.2M | 1 | -50% | N/A | N/A | 
| #3 | $6.2M | 40 | 21% | N/A | N/A | 
| #4 | $42.2M | 218 | 4% | $165M | N/A | 
| #5 | $14.6M | 94 | -37% | $312.8M | N/A | 
| #6 | $0.3M | 2 | -67% | N/A | N/A | 
| #7 | $235M | 366 | -5% | $340.9M | N/A | 
| #8 | $56M | 289 | -7% | $7.6M | N/A | 
| #9 | $4.7M | 61 | 36% | N/A | N/A | 
| #10 | $2M | 13 | 8% | N/A | N/A | 
What Is Hyku Biosciences?
With a singular goal to improve patient lives, Hyku is pioneering precise covalent targeting of disease-causing proteins and transforming conventional treatment paradigms
keywords:N/A$64M
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | 
|---|---|---|---|---|
| #1 | $4.2M | 27 | 0% | N/A | 
| #2 | $3.1M | 27 | 13% | N/A | 
| #3 | $5.1M | 27 | 13% | N/A | 
| #4 | $5.1M | 27 | 17% | N/A | 
| #5 | $5.4M | 27 | 23% | N/A | 
